Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NDUFS8 | O00217 | 3/20 | 0.39 |
| ▸ | COXFA4 | O00483 | 3/20 | 0.39 |
| ▸ | NDUFAB1 | O14561 | 3/20 | 0.39 |
| ▸ | NDUFA1 | O15239 | 3/20 | 0.39 |
| ▸ | NDUFS4 | O43181 | 3/20 | 0.39 |
| ▸ | NDUFB5 | O43674 | 3/20 | 0.39 |
| ▸ | NDUFB3 | O43676 | 3/20 | 0.39 |
| ▸ | NDUFC1 | O43677 | 3/20 | 0.39 |
| ▸ | NDUFA2 | O43678 | 3/20 | 0.39 |
| ▸ | NDUFS5 | O43920 | 3/20 | 0.39 |
| ▸ | NDUFS7 | O75251 | 3/20 | 0.39 |
| ▸ | NDUFS2 | O75306 | 3/20 | 0.39 |
| ▸ | NDUFS6 | O75380 | 3/20 | 0.39 |
| ▸ | NDUFB1 | O75438 | 3/20 | 0.39 |
| ▸ | NDUFS3 | O75489 | 3/20 | 0.39 |
| ▸ | NDUFB6 | O95139 | 3/20 | 0.39 |
| ▸ | NDUFA3 | O95167 | 3/20 | 0.39 |
| ▸ | NDUFB4 | O95168 | 3/20 | 0.39 |
| ▸ | NDUFB8 | O95169 | 3/20 | 0.39 |
| ▸ | NDUFB2 | O95178 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2863861 | 1.00 | NDUFS8 (0.39) | NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4 | |
| SCHEMBL2859375 | 0.81 | LSS (0.39) | KMT2AALDH1A1TRPV1 | |
| SCHEMBL2859377 | 0.81 | LSS (0.39) | KMT2AALDH1A1TRPV1 | |
| SCHEMBL2866504 | 0.77 | LMNA (0.39) | LMNAMTNR1AMTNR1BSMN1; SMN2AOC3 | |
| SCHEMBL2866505 | 0.77 | LMNA (0.39) | LMNAMTNR1AMTNR1BSMN1; SMN2AOC3 | |
| SCHEMBL4762469 | 0.75 | PTPN1 (0.57) | HPGDPTPN1TRPV1 | |
| SCHEMBL14273810 | 0.75 | PTPN1 (0.57) | HPGDPTPN1TRPV1 | |
| SCHEMBL2866630 | 0.75 | PTPN1 (0.34) | ALDH1A1PTPN1 | |
| SCHEMBL2866628 | 0.75 | PTPN1 (0.34) | ALDH1A1PTPN1 | |
| SCHEMBL2868632 | 0.75 | LSS (0.40) | NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7728180-B2 | Method for producing ethers | KURARAY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20080262272-A1 | Method For Producing Ethers | KURARAY CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| EP-1760061-A1 | METHOD FOR PRODUCING ETHERS | KURARAY CO., LTD. (JP) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262272-A1 | Method For Producing Ethers | TELO2, PDS5A, TERT | NDUFS8 1699/4885COXFA4 1682/4885NDUFAB1 3675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.